AB Science S.A. (OTCMKTS:ABSCF) Short Interest Down 16.7% in August

AB Science S.A. (OTCMKTS:ABSCF) was the target of a significant drop in short interest in the month of August. As of August 15th, there was short interest totalling 500 shares, a drop of 16.7% from the July 31st total of 600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

AB Science Price Performance

ABSCF opened at $1.06 on Friday. The company has a fifty day moving average price of $1.98 and a two-hundred day moving average price of $2.67. AB Science has a 1-year low of $1.06 and a 1-year high of $1.06.

About AB Science

AB Science SA, a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19.